DOCUPRENE  - docusate sodium tablet 
Pharmaceutica North America, Inc.

----------

DOCUPRENE

Active Ingredient (in each tablet)                              Purpose

Sodium Dioctyl Sulfosuccinate          100mg             Stool Softner 

Each tablet contains 8 mg. of Sodium

Inactive Ingredients

Croscamellose Sodium, Dicalcium Phosphate, Magnesium Silicate, Magnesium Stearatem Microcrystalline Cellulose, Pharmceutical Glaze, Silica, Sodium Benzoate and Stearic Acid.

Uses:

For the prevention of dry hard stools

For relief of occasional constipation

This product generally produces bowel movement with 12 to 72 hours.


Warnings

Do not use laxative products for longer that one week unless directed to do so by a doctor and if you are presently taking mineral oil, unless told to do so by a doctor.

Ask a doctor before use if you have: Abdominal pain, nausea, vomiting, noticed a sudden change in or you fail to have a bowel movement after use. These could be signs of a serious condition.

If pregnant or breast-feeding , ask a doctor before use.

Other Information  

Store at room temperature 68- 77 degrees F

For Questions or Comments

Please email: info pnarx.com

or Call: 877-329-2592

Keep out of reach of children

In case of overdose, get medical help or contact a Poison Control Center right away.

Adults and children 12 years of age and older: Take 1 or 2 tablets daily

Children Under 12 years of age: Do not use, Consult a doctor before use.

NDC 45861-0201-60  

DOCUPRENE

100 mg

Sodium Dioctyl Sulfosuccinate

60 Tablets

Made in USA

Patent Pending

Manufactured For

Pharmaceutica America Glendale CA

Docuprene


DOCUPRENE 
docusate sodium   tablet
Product Information
Product TypeHUMAN OTC DRUGNDC Product Code (Source)45861-201
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM
Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found
Product Characteristics
Colorwhite (White) Score no score
ShapeROUNDSize11mm
FlavorImprint Code CPC513
Contains    
Packaging
#NDCPackage DescriptionMultilevel Packaging
145861-201-6060 TABLET In 1 BOTTLENone

Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33406/16/2010

Labeler - Pharmaceutica North America, Inc. (962739699)
Establishment
NameAddressID/FEIOperations
Contract Pharmacal Corporation057795122manufacture
Revised: 06/2010Pharmaceutica North America, Inc.